Harvey J. Alter
Who was Harvey J. Alter?
Nobel laureate: Nobel Prize in Physiology or Medicine (2020)
Biographical data adapted from Wikipedia’s article on Harvey J. Alter (CC BY-SA 4.0).
Biography
Harvey James Alter was born on September 12, 1935, in New York City and became one of the most important medical researchers of the late 20th century. After finishing his education at the University of Rochester, Alter focused his career on understanding viral hepatitis and blood-borne infections. He joined the National Institutes of Health (NIH) in Bethesda, Maryland, where he was the chief of the infectious disease section and associate director for research at the Department of Transfusion Medicine at the Warren Grant Magnuson Clinical Center.
Alter's pivotal work began in the mid-1970s when he and his team investigated cases of post-transfusion hepatitis that were not caused by the known hepatitis A or B viruses. Through careful epidemiological studies and transmission experiments using chimpanzees, Alter found that a previously unknown infectious agent was responsible for these cases. Working independently alongside Edward Tabor from the U.S. Food and Drug Administration, he proved that this new form of hepatitis, initially called "non-A, non-B hepatitis," was caused by a virus.
This research laid the groundwork that eventually led to the identification of the hepatitis C virus in 1988. Alter's careful methods involved tracking blood samples from patients who developed hepatitis after transfusions, ruling out known causes, and showing that the unknown pathogen could be transmitted. His work was key in proving the existence of what we now know as hepatitis C, even though the actual virus was isolated later by other researchers.
The impact of Alter's discoveries is enormous. His research made blood transfusions safer worldwide and helped identify a major cause of chronic liver disease, cirrhosis, and liver cancer. The hepatitis C virus affects an estimated 170 million people globally, making Alter's contributions to its discovery crucial for international public health. In recognition of his achievements, he was awarded the Nobel Prize in Physiology or Medicine in 2020, sharing the honor with Michael Houghton and Charles M. Rice for their work on discovering the hepatitis C virus.
Before Fame
Growing up in New York City during the Great Depression and World War II, Alter experienced a time of rapid advancement in medical science and virology. The 1940s and 1950s brought major breakthroughs in understanding viral diseases, including the development of polio vaccines and early discoveries about viral hepatitis. This era of scientific optimism and government support for medical research after the war created a setting where young researchers like Alter could pursue ambitious studies on infectious diseases.
Alter's education at the University of Rochester gave him the strong scientific training needed to tackle complex viral diseases. After the war, the medical research community, especially the growth of the National Institutes of Health, provided unique opportunities for ongoing research into infectious diseases that had long challenged the medical community.
Key Achievements
- Discovered the existence of non-A, non-B hepatitis through transmission studies in chimpanzees
- Provided foundational research leading to the identification of hepatitis C virus in 1988
- Served as chief of infectious disease section at NIH's Department of Transfusion Medicine
- Received Nobel Prize in Physiology or Medicine in 2020 for hepatitis C virus discovery
- Won multiple prestigious medical awards including Lasker Award and Canada Gairdner International Award
Did You Know?
- 01.Alter's research used chimpanzees as test subjects because they were the only non-human animals that could be infected with human hepatitis viruses
- 02.He spent over a decade studying what was called 'non-A, non-B hepatitis' before the actual hepatitis C virus was identified and isolated
- 03.Alter maintained frozen blood samples from hepatitis patients for years, which proved crucial when new testing methods became available
- 04.His work began with investigating why some patients who received blood transfusions developed hepatitis despite screening for known hepatitis viruses
- 05.The hepatitis C virus he helped discover was initially so difficult to detect that it was called the 'ghost virus' by some researchers
Awards & Honors
| Award | Year | Details |
|---|---|---|
| Nobel Prize in Physiology or Medicine | 2020 | for the discovery of Hepatitis C virus |
| Canada Gairdner International Award | 2013 | — |
| Lasker-DeBakey Clinical Medical Research Award | 2000 | — |
| Prix International de l’INSERM | 2004 | — |
| Karl Landsteiner Memorial Award | 1992 | — |
| Public Health Service Distinguished Service Medal | 1977 | — |
| James Blundell Prize | 1999 | — |